KARA DOYLE: Open Payments
NPI 1841547726 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 75 payments from 17 companies in 2025. Trend: 2023 $746 · 2024 $623 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $256 |
| Novo Nordisk Inc | 17 | $216 |
| PFIZER INC. | 6 | $99 |
| Amgen Inc. | 6 | $89 |
| Collegium Pharmaceutical, Inc. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $79 |
| GlaxoSmithKline, LLC. | 4 | $60 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $36 |
| Dexcom, Inc. | 2 | $35 |
Products named: Ozempic, QULIPTA, Jornay PM, Kerendia, PREVNAR 20, VRAYLAR, UBRELVY, SHINGRIX.
Industry payments across IN — which companies pay providers there.
